Chesworth Richard
SEC CIK 1821188 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KYMR | Kymera Therapeutics, Inc. | CSO | 33.8K | — | $4.75M | 4 | 2021-08-17 | 2021-08-27 |
Most active insiders at KYMR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Booth Bruce | Dir | — | $226.03M |
| 2 | BVF PARTNERS L P/IL | Dir, See Remarks, Footnotes | — | $173.67M |
| 3 | BAKER FELIX | Dir, 10% | $172.50M | — |
| 4 | Mainolfi Nello | CEO, Dir | — | $33.41M |
| 5 | Chadwick Jeremy G | COO | — | $15.60M |
| 6 | Jacobs Bruce N. | CFO | — | $9.96M |
| 7 | Gollob Jared | Chief Medical Off | — | $9.13M |
| 8 | Esposito Pamela | Dir | — | $3.05M |
| 9 | Goodman Noah | Chief Business Off | — | $2.22M |
| 10 | Ridloff Elena | Dir | — | $1.29M |
Chesworth Richard made no open-market trades at KYMR in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-27 | 2021-08-27 | KYMR | Kymera Therapeutics, Inc. | Chesworth Richard | CSO | M - OptEx | $20.00 | +33.8K | 33.8K | New | +$675.6K |
| D | 2021-08-27 | 2021-08-27 | KYMR | Kymera Therapeutics, Inc. | Chesworth Richard | CSO | S - Sale+OE | $60.12 | -33.8K | 0 | -100% | -$2.03M |
| DM | 2021-08-19 | 2021-08-17 | KYMR | Kymera Therapeutics, Inc. | Chesworth Richard | CSO | S - Sale+OE | $50.37 | -54.0K | 45.2K | -54% | -$2.72M |
| D | 2021-08-19 | 2021-08-17 | KYMR | Kymera Therapeutics, Inc. | Chesworth Richard | CSO | M - OptEx | $20.00 | +54.0K | 54.0K | New | +$1.08M |
Purchase Sale Sale after option exercise All abbreviations